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To determine the effects of 1) a condom distribution program and 2) a condom distribution
program combined with opt-out sexually transmitted infection (STI) screening on the trans-
mission and prevalence of STIs in a prison system.
Methods
Using data from an implementation evaluation of a state-wide prison condom program and
parameter estimates from available literature, a deterministic model was developed to
quantify the incidence and prevalence of sexually transmitted HIV, hepatitis B, chlamydia,
syphilis and gonorrhoea across 14 Victorian prisons. The model included individual prison
populations (by longer (>2 years) or shorter sentence lengths) and monthly prisoner trans-
fers. For each STI, simulations were compared: without any intervention; with a condom dis-
tribution program; and with a combined condom and opt-out STI screening at prison
reception intervention program.
Results
Condoms reduced the annual incidence of syphilis by 99% (N = 66 averted cases); gonor-
rhoea by 98% (N = 113 cases); hepatitis B by 71% (N = 5 cases); chlamydia by 27% (N =
196 cases); and HIV by 50% (N = 2 cases every 10 years). Condom availability changed
the in-prison epidemiology of gonorrhoea and syphilis from self-sustaining to levels unlikely
to result in infection outbreaks; however, condoms did not reduce chlamydia prevalence
below a self-sustaining level due to its high infectiousness, high prevalence and low detec-
tion rate. When combined with a screening intervention program, condoms reduced chla-
mydia prevalence further, but not below a self-sustaining level. The low prevalence of HIV
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and hepatitis B in Australian prisons meant the effects of condoms were predicted to be
small.
Conclusion
Condoms are predicted to effectively reduce the incidence of STIs in prison and are pre-
dicted to control syphilis and gonorrhoea transmission, however even combined with a
screening on arrival program may be insufficient to reduce chlamydia prevalence below
self-sustaining levels. To control chlamydia transmission additional screening of the existing
prison population would be required.
Introduction
Prisoners experience markedly poorer physical and mental health and elevated risk of disease
compared to the general community, often compounded by entrenched disadvantage and drug
dependence [1–3]. Among prisoners in Australia there is a high prevalence of hepatitis C and
hepatitis B [4], and although the prevalence of HIV is estimated to be low compared to other
developed nations’ prisons, it is still greater than in the general Australian community [5].
While a self-reported history of one or more sexually transmitted infections (STIs) is common
among prisoners [6, 7], estimates of the biological prevalence of STIs in prison is less clear. STI
testing rarely occurs for males despite the provision of voluntary testing offered at both original
reception to prison and upon subsequent transfers [8]. Further, the limited biological preva-
lence studies show inconsistent findings: a chlamydia surveillance programme in New South
Wales (NSW) prisons between 2005 and 2007 found a chlamydia notification rate approxi-
mately four times higher than the general community [9]; however national surveillance
among a limited number of prisoners across Australian jurisdictions showed rates of STIs simi-
lar to the general Australian population [4].
Despite paucity of information regarding the rate and burden of disease associated with
STIs in Australian prisons, there is evidence on behaviours amongst prisoners that suggest the
prison setting itself is a high risk environment for STI transmission between prisoners and
potentially to the general community following prisoner release. Studies of prisoner risk behav-
iour in Victoria and NSW demonstrated continued risk for blood borne virus (BBV) and STI
transmission through unprotected sex and injecting and tattooing with unsterile equipment [4,
5, 10–15], alongside widespread reports among prisoners of sexual activity in prisons without
condoms being available [16]. Closed settings where sexual risk behaviours are known to occur
provide ideal settings for STI outbreaks should undetected (and untreated) infections enter the
susceptible population [17, 18], with outbreaks of syphilis, gonorrhoea and hepatitis B being
reported in prisons previously [19]. Australia’s Third National Sexually Transmissible Infec-
tions Strategy 2014–2017 [20] includes people in custodial settings as a high-risk priority popu-
lation for the prevention of STIs, noting that prisoners often have limited access to STI
education and prevention tools prior to incarceration and that this is compounded by similar
limited access in prison.
Condoms are an effective public health and harm minimisation measure to reduce trans-
mission of STIs and some BBVs [21]. The restricted movements of prisoners and associated
stigma make it unrealistic to expect 100% efficacy from a condom distribution program and so
further intervention will likely be required to prevent outbreaks. An opt-out STI screening pro-
gram on arrival to prison for STIs may offer an additional opportunity to eliminate treatable
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STIs such as chlamydia, gonorrhoea and syphilis and thus prevent onward transmission. Simi-
lar opt-out screening programs in community settings have been shown to be successful in dra-
matically increasing rates of screening and treatment [22].
In this paper we use data from an implementation evaluation of a jurisdiction-wide prison
condom program and parameter estimates from available literature to report on models esti-
mating changes to the epidemiology of STIs that are likely to occur subsequent to: 1) the intro-
duction of a condom distribution program in a prison system; and 2) the introduction of
condoms, in conjunction with an opt-out screening on arrival strategy.
Methods
A deterministic (equation based) model was used to quantify the incidence and prevalence of
sexually transmitted HIV, hepatitis B, syphilis, chlamydia and gonorrhoea in all 14 adult male
prisons in Victoria.
Setting
Victoria is the second most populous state in Australia and has 14 prisons, 12 publically oper-
ated and 2 privately operated. All Victorian prisons are managed by Corrections Victoria and
overseen by the Victorian Department of Justice. At June 30th 2013, Victoria had a male incar-
ceration rate of 227 per 100,000 males per year and a total male prison population of 4,964
(representing 93% of the total prison population). The median age of a Victorian prisoner was
35.3 years, 7% were indigenous (the lowest of all states and territories in Australia), and 25%
were born overseas, most commonly in Vietnam. Prisoners were incarcerated for offences clas-
sified as: acts intended to cause injury (15.9%); offences against justice procedures, government
security and operations (14.9%); sexual assault (12.7%); illicit drugs (11.9%); unlawful entry
with intent (10.3%); homicide (8.9%); and robbery and extortion (8.4%). Further details are
available from the Australian Bureau of Statistics [23].
In Australia, condoms are currently available in prisons in the Australian Capital Territory
and the states of New South Wales, South Australia and Western Australia [12, 24]; however
prior to the condom distribution program considered in this analysis, no condoms were avail-
able to prisoners in Victoria.
Data sources
For the period July 2012 to June 2013 monthly prison populations, receptions, discharges and
transfers were obtained from Corrections Victoria for 14 male prisons, decomposed as either
long (more than two years) or short sentences. For each prison (i = 1,. . .,14), the monthly aver-
ages for prison population (Pi), proportion of prisoners serving short sentences, number of
short and long sentence discharges (Nsi and Nli respectively), number of transfers between
each of the other 13 prisons, and number of condoms distributed (Disti) were calculated and
used to define populations, movements and turnovers within the model. Across prisons, the
median prison population was 332 (inter quartile range (IQR) 223–396), the median propor-
tion of prisoners serving a short sentence was 0.5 (IQR 0.38–0.62), the median short sentence
and long sentence discharge rates were 16.4% (IQR 11.5–22.1%) per month and 2.0% (IQR
1.1–2.9%) per month respectively, and the median number of condoms distributed in each
prison was 65 (IQR 24–98) per month.
Estimates from the literature were found for: the proportion of prisoners who are sexually
active (Sex), the proportion of distributed condoms used for sex (Used), the proportion of total
sexual acts that would use condoms when available (Condom), the prevalence of each STI in
the community (Cinf), hepatitis B community vaccination rate (VacC), hepatitis B prison
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population vaccination rate (VacP), the proportion of the prison population with prior incar-
ceration (Prior), STI transmission risks per sexual act (β), STI incubation periods (γ), STI
detection window periods (ω), STI detection and treatment rates (τ), and STI treatment lengths
(η). A description of parameters and their sources is provided in Table 1.
Model description
Independent models were used for the sexual transmission of HIV, hepatitis B, syphilis, chla-
mydia and gonorrhoea, as described below. Complete equations for each of these models are
provided in the supporting information (S1 File).
Single prison model, HIV, syphilis, chlamydia and gonorrhoea. Prisoners were classi-
fied as either: U—not sexually active in prison and uninfected; V—not sexually active in prison
and infected; S—sexually active in prison and not infected; L—sexually active in prison and
infected, with disease in latent period; I—sexually active in prison and infected; or T—sexually
active in prison and in treatment for a current infection.
New receptions to prison i (Nsi + Nli prisoners each month) were apportioned into the Ui,
Vi, Si and Ii compartments according to whether or not they were likely to: be sexually active in
prison (Sex); have had prior incarceration (Prior); be infected based on community infection
prevalence if they had no history of incarceration (Cinf); and be infected based on the greater
of current prison infection prevalence or community infection prevalence if they had a history
of incarceration (Pinf), as shown in Fig 1, left panel. The prevalence of infection among new
arrivals with a history of incarceration was selected in this way to represent both the additional
STI exposure of these prisoners, and their socio-economic disadvantage in the community.
During each month: λSi susceptible prisoners became infected with the latent disease (where λ
is the force of infection defined in Table 1); (1/γ)Li prisoners moved from the latent phase to
infection phase; τIi infected prisoners undertook treatment for the disease; (1/η)Ti prisoners
were successfully treated; and infected but not sexually active prisoners were detected and
treated at a rate of ((1/τ)+η)-1. Discharged prisoners were assumed to come with equal proba-
bility from each compartment, at rates balanced to maintain a constant prison population (Fig
1, right panel).
Single prison model, hepatitis B. The model for hepatitis B differed due to the existence of
vaccinations and immunity conferred through past exposure. For this model, new arrivals were
apportioned with the additional consideration that if they were vaccinated or had past expose
(according to community vaccination rates (VacC) or prison vaccination rates (VacP) for the
proportion with prior incarceration) they were moved into the U compartment regardless of sex-
ual activity (see S1 Fig). The number of sexual acts per month per sexually active prisoner was
also reduced by a factor [Prior(1-VacP)+(1-Prior)(1-VaccC)], which is the probability of
involving an unvaccinated prisoner (an additional requirement for infection in this model).
Prisoner transfers. The above models were applied to each of the 14 prisons, which were
then linked by a prisoner transfer matrix, allowing movements between prisons. Transfers
were assumed to be independent of sexual activity and STI status. Details are provided in the
supporting information (S1 File).
Screening on arrival. To capture the effects of a STI screening on arrival initiative, the mod-
els were expanded to include six additional ‘pre-screen’ compartments (U’, S’, L’, I’, T’ and V’),
with dynamics mirroring the original ones. A proportion (screen) of new arrivals—including
from a prison transfer—entered the model into the pre-screen compartments where they could
still interact as before with the entire population. They were then screened (at an estimated
screening rate ρ) and moved into the original compartments: those who were susceptible, in
treatment or infected moved to the original susceptible, treatment or treatment compartments
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Table 1. Parameters used to model sexual activity, STI infection rates, STI transmission and treatment rates and STI screening rates in Victorian
prisons.
Parameter Description Breakdown Value Source
Sexual activity
Sex Proportion prisoners sexually active 0.09 Butler et al. 2010a [25]
Used Proportion of distributed condoms used
for sex
0.40 Dolan et al. 2004 [12]
Condom Proportion of sexual acts using condoms
(when available)
0.52 Dolan et al. 2004 [12]
Acts Number of sex acts per month for each
sexually active prisonerb.
Dist Used
P Sex  Condom Estimation of sexual activity based on thenumber of condoms distributed, and
estimations of the proportion used for sex and
proportion of sexually active individuals.
Infection rates
Cinf Community prevalence (closest
estimates to prison demographic:
interquartile age range 25–45 years, 93%
male 7% female)
HIV 0.2% UNAIDS [26]
Hepatitis B 1.7% (25–39 year olds) Butler et al. 2011 [4]
Syphilis 0.26% (men) WHO 2005c [27]
Chlamydia 3.9% (men <30) Lewis et al. 2012 [28]
Gonorrhoea 0.52% (men) WHO 2005c [27]
VacHB Hepatitis B vaccination rate Community 30% Expert opinion
Prisoners 50% (males, 2010) Butler et al. 2011 [4]
Prior Proportion of new prisoners with prior
incarceration
0.48 Department of Justice
Pinf Current prison prevalence Iþ Lþ T þ V
P
Infected proportion of prisoners in the model at
any point in time.
Transmission and treatment rates
β Risk of transmission per sex act d HIV 0.014 Baggaley et al. 2010 [29]
β “ Hepatitis B 0.07 Expert opinion
β “ Syphilis 0.15 Wilson et al. 2010 [30]
β “ Chlamydia 0.35 Gray et al. 2009 [31]
β “ Gonorrhoea 0.22 Wilson et. al. 2010 [30]
λ Risk of transmission per month β x (1-Condom) x Acts x
(proportion infectious sexually
active prisoners)
Likelihood of becoming infected each month
for a given level of sexual activity, transmission
risk per act, probability of using a condom
each time and current infection rate among
possible partners. Prisoners who are infected
and on treatment are assumed to be infectious
for all STIs except HIV, where antiretroviral
therapy is assumed to supress the virus
enough that transmission is negligible [32].
τ Effective detection and treatment ratee HIV 1/18 The Kirby Institute 2014 [33]; using estimated
time from initial infection to a CD4 count of 432
—the reported Australian average on
diagnosis—and the guidelines to treat at any
CD4 count in Australia [34, 35].
τ “ Hepatitis B 1/12 Expert opinion
τ “ Syphilis 1/2 Expert opinion
τ “ Chlamydia 1/12 Expert opinion
τ “ Gonorrhoea 1 Expert opinion
η Effective treatment length HIV Lifetime Expert opinion
η “ Hepatitis B 6 months (90%); Lifetime (10%) WHO [27]
η “ Syphilis 1 week Melbourne sexual health centre 2012 [36]
η “ Chlamydia 1 week Melbourne sexual health centre 2012 [36]
η “ Gonorrhoea 1 week Melbourne sexual health centre 2012 [36]
(Continued)
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respectively, while those who had latent disease moved to the original treatment compartment if
they had passed their detection window, or to the original latent compartment if they had not
(Fig 2). Discharges and transfers were assumed to come with equal probability from each of the
12 compartments, and for the hepatitis B model, a screening program was considered to include
vaccination, so that the S’ compartment flowed into the U compartment instead of S.
Model uncertainty
The literature around the sexual behaviours and STI prevalence among prisoners is sparse, and
studies often experience low response rates and struggle to obtain accurate parameter esti-
mates. To test model robustness, a Monte Carlo uncertainty analysis was conducted. Here we
defined the uncertainties of individual parameters, parameterised this uncertainty as a proba-
bility distribution of each parameter and undertook multiple simulations using random, inde-
pendent parameter draws. We developed 95% credible intervals (95%CrI) for the resulting STI
prevalence and reduction in incidence after each intervention by taking the central 95% of out-
comes (i.e. the 2.5–97.5 percentiles) of 2000 alternate runs. Beta distributions were used to esti-
mate the uncertainty around the parameters Sex, Used, Condom, Prior, ρ, screen, VacHB,
Cinf, β, τ, γ and ω. The distributions used for each parameter are provided in S1 Table, and
plotted in S2 Fig and S3 Fig.
Results
Prevalence and incidence
The model predicts that the availability of condoms alone would reduce the annual number of
sexually acquired cases of: hepatitis B by 71% (N = 5 averted cases); syphilis by 99% (N = 66
Table 1. (Continued)
Parameter Description Breakdown Value Source
γ Duration of latency HIV 1 week WHO 2015 [34]
γ “ Hepatitis B 6 months WHO 2005 [27]
γ “ Syphilis 3 weeks Heymann 2008 [37]
γ “ Chlamydia 1.5 weeks Heymann 2008 [37]
γ “ Gonorrhoea 1 week Heymann 2008 [37]
ω Detection window period HIV 3 weeks Rosenberg et al. 2015 [38]
ω “ Hepatitis B 4 weeks Expert opinion
ω “ Syphilis 2.5 weeks Expert opinion
ω “ Chlamydia 1 week Expert opinion
ω “ Gonorrhoea 5 days Expert opinion
Screening intervention
ρ Screening rate 1 month Assumed
screen Proportion who are screened 95% Assumed
a No evidence was available to support the stratification Sex by sentence length.
b A minimum of one sexual act per month is assumed for sexually active prisoners.
c Western Pacific region (men).
d The transmission risk associated with a single type of sexual contact is assumed for each STI: HIV is for unprotected anal; HBV is estimated as 5 times
that of HIV; syphilis, chlamydia and gonorrhoea are for unprotected vaginal (unprotected anal estimates were unavailable).
eIncludes spontaneous clearance of STIs (except HIV) in the absence of treatment.
doi:10.1371/journal.pone.0144869.t001
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averted cases); chlamydia by 27% (N = 196 averted cases); gonorrhoea by 98% (N = 113 averted
cases); and HIV by 50% (N = 2 averted cases every 10 years). Augmenting this with a screening
on arrival program led to a further 15% reduction in incident cases of hepatitis B (N = 1 addi-
tional case from condoms alone), a further 4% reduction in incident cases of chlamydia
(N = 26 additional cases from condoms alone), a further 1% reduction in incident cases of
gonorrhoea (N = 1 additional case from condoms alone) and had no effect on HIV and syphilis
incidence (Fig 3).
Condoms were able to virtually control the transmission of syphilis and gonorrhoea.
Despite preventing a number of new hepatitis B infections, the availability of condoms did not
stop low level transmission. The addition of a screening intervention to condom distribution
made little impact on the number of averted hepatitis B, syphilis and gonorrhoea infections per
year, however it led to further reductions hepatitis B, chlamydia, syphilis and gonorrhoea prev-
alence. HIV prevalence was so low that the effects of condoms and screening were small.
Uncertainty analysis
Outcomes produced by point estimates using parameters from Table 1 were very close to
median values from the sensitivity analysis (Table 2) and appear reasonable estimates of the
prevalence and prevented infections in each scenario. The number of averted infections per
year when condoms were introduced was slightly right skewed for HIV, hepatitis B and chla-
mydia with medians 0.17, 5 and 172 respectively, while syphilis and gonorrhoea both had high
proportions of outcomes with fewer than 50 infections per year prevented and long tails
extending to some realisations near 600 (Table 2, S4 Fig).
Fig 1. Single prison HIV, syphilis, chlamydia and gonorrhoea model. Each month Nsi+Nli new prisoners arrived in prison i and were apportioned to
compartments according to sexual activity in prison, prior incarceration status and community or prison infection prevalence (left). Prisoners could then move
between compartments in the model or leave if discharged (right).
doi:10.1371/journal.pone.0144869.g001
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Discussion
These models have demonstrated that as each of the STIs considered are in different epidemic
stages within the prison system different responses are required.
For syphilis and gonorrhoea, condoms were able to eliminate the possibility of self-sustain-
ing outbreaks and virtually eliminate new infections from the system. For these infections, the
basic reproduction ratio (R0)—the expected number of new infections that occur when a
typical infected case arrives in a fully susceptible population (R0 = Acts(1-Condom)β/τ,
[39])—was less than but close to one at default parameters, and above one for some part of the
parameter space sampled in the uncertainty analysis (as evidenced by the large 95%CrIs in
Table 2). In general, a preventative intervention for an infectious disease will be most effective
if it can cause a change in R0 from above one to below one. For syphilis and gonorrhoea, con-
doms were able to achieve this for the majority of the simulations (see S4 and S5 Figs). Further,
if R0 is close to exceeding R0 = 1, sporadic outbreaks may be seen in the prison system and,
once introduced, these infections may become self-sustaining. By shifting R0 away from this
threshold condom use has made outbreaks of syphilis and gonorrhoea such as those previously
seen internationally [40–42] significantly less likely.
The model predicts that chlamydia is self-sustaining within the prison system, and due its
higher prevalence and transmissibility, condoms, a screening on arrival program and testing
Fig 2. Single prison HIV, syphilis, chlamydia and gonorrhoea model with screening on arrival. After new arrivals entered the ‘pre-screen’ (lighter)
compartments, their movements mirrored the original (darker) compartments where they moved to after they were screened.
doi:10.1371/journal.pone.0144869.g002
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and treatment of the existing prison population would be required in order to completely con-
trol the possibility of outbreaks. Compared to syphilis and gonorrhoea, the higher transmissi-
bility and longer detection times (due to more asymptomatic cases [43]) results in R0 being
above one for chlamydia, even when condoms are available. Thus, despite being successful at
reducing incidence, condom use was not sufficient to control transmission, and although
Fig 3. Total incidence and prevalence. Estimated incident infections per annum from unsafe sex (left) and in-prison prevalence of STIs (right) with no
intervention, after condoms were made available and with a combined condoms and a screening on arrival intervention.
doi:10.1371/journal.pone.0144869.g003
Table 2. Comparison of model outcomes for STI prevalence and infections averted using point estimates to those from aMonte Carlo uncertainty
analysis.
Point Estimate Sensitivity analysis median (2.5,97.5 percentile)
No intervention Condoms Condoms + screen No intervention Condoms Condoms + screen
Prevalence
HIV 0.21% 0.20% 0.20% 0.19% (0.01–4.79) 0.19% (0.07–0.40) 0.19% (0.07–0.40)
Hepatitis B 1.26% 1.18% 0.63% 1.16% (0.34–2.68) 1.07% (0.31–2.51) 0.59% (0.17–1.46)
Syphilis* 0.31% 0.06% 0.01% 0.27% (0.01–2.04) 0.06% (0.01–0.18) 0.01% (0.00–0.19)
Chlamydia 6.8% 4.8% 4.1% 9.0% (6.8–11.0) 7.2% (4.2–9.5) 4.4% (2.3–6.1)
Gonorrhoea* 0.30% 0.07% 0.02% 0.30% (0.04–1.60) 0.07% (0.03–0.14) 0.02% (0.01–0.10)
Infections averted per year
HIV 0.2 0.2 0.17 (0.01–4.79) 0.17 (0.01–4.79)
Hepatitis B 5 6 5 (1–16) 6 (1–19)
Syphilis* 66 67 54 (0–479) 55 (0–466)
Chlamydia 196 222 172 (62–489) 193 (0–523)
Gonorrhoea* 113 114 108 (1–677) 109 (1–681)
*Due to the large right skew of infections prevented and prevalence, the 0–95 percentiles have been used as the 95%CrI.
doi:10.1371/journal.pone.0144869.t002
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further reducing incidence, combining condom use with screening on arrival was also insuffi-
cient to control transmission. This is particularly problematic, given that the data available sug-
gests that chlamydia is by far the most prevalent STI in Victorian prisons and in the Australian
community [28].
Despite preventing a number of hepatitis B transmissions, availability of condoms will not
stop low level transmission of hepatitis B, as a result of long treatment times and the possibility
of chronic infection. However if condom availability were combined with vaccination of all
prisoners on arrival, the transmission of hepatitis B could be completely controlled. Similarly,
the prevalence of HIV is so low in Victorian prisons that the effects of condoms are predicted
to be small. This would not be the case in many international settings, where HIV prevalence
in prison can exceed 10% [44]. Nevertheless, the high and ongoing costs associated with treat-
ing HIV and chronic hepatitis B mean that even a few averted cases are likely to have signifi-
cant cost benefits.
The importance of condoms to prevent STI transmission have been known for some time
[21]. In particular, condoms have already been made available in some European, Canadian
and Australian (excluding Victorian) prisons, where they have been found to be effective, with
no evidence of condom availability resulting in increases in prison sexual activity, sexual
assaults or other adverse incidents [11, 12, 24, 45–47]. Given the clear benefits highlighted by
these models and the lack of negative consequences reported from distribution programs else-
where, the provision of condoms to such a highly vulnerable population is a simple harm
reduction initiative that falls under a basic duty of care, offering some level of protection both
to prisoners and the community upon their release.
This paper has several limitations. First, information about the health and sexual behaviour
of prisoners is difficult to obtain, and these models would benefit from more information on
the prevalence of STIs on arrival and many of the other parameter estimates used. Such data
would allow better calibration and improve accuracy and predictive power. Second, the
assumption that 9% of prisoners were sexually active may be an under-estimate as it is based
on self-reported data from Butler et al. [25]. However conversely, the risk of STI transmission
between prisoners in the model may be over-estimated, since the model has assumed a single
transmission risk associated with a single type of sexual contact for each STI; in the Butler et al.
study prisoners reported different forms of sexual contact that have varying STI transmission
risks—for example the risk of HIV transmission through oral sex is minimal compared to the
risk through unprotected anal intercourse. A single transmission risk was used in the model as
a result of the limited data available to separate sexual activity by type, and the limited studies
estimating the transmission probability per sexual act for different types of sexual contact. We
have instead attempted to capture the effects of different sexual contact types by varying the
average transmission probabilities in the uncertainty analysis. Third, the models have assumed
no interaction between STIs, and that transmission occurs only through sexual contact (i.e. no
hepatitis B or HIV transmission through needle sharing). These are conservative assumptions
and may understate prevalence, as for example, people with HIV are more likely to develop
chronic hepatitis B [48] and are more susceptible to other STIs, meaning that where transmis-
sion through other mediums is possible the likelihood of sexual transmission is also higher.
This explains why for hepatitis B and gonorrhoea the prevalence in prison is slightly lower
than the estimates of community prevalence, and we emphasize that the model has only been
used to calculate relative changes in STI epidemiology as a result of changes to sexual transmis-
sion. Fourth, deterministic models assume perfect mixing of sexual partners within each prison
regardless of sentence length or prior incarceration status; however there are few studies moni-
toring sexual networks in prisons meaning that data is limited and unlikely to be accurate
enough to inform network models.
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Conclusions
The introduction of condoms in Victorian prisons is predicted to avert a number of STI trans-
missions. The model estimates that the availability of condoms could reduce the annual inci-
dence syphilis by 99% (N = 66 averted cases); gonorrhoea by 98% (N = 113 cases); sexually
acquired hepatitis B by 71% (N = 5 cases); chlamydia by 27% (N = 196 cases); and sexually
acquired HIV by 50% (N = 2 cases every 10 years). The model predicted that augmenting a
condom distribution program with a screening on arrival program would provide only modest
additional gains, further reducing the annual incidence of gonorrhoea by 1% (N = 1 case), sex-
ually acquired hepatitis B by 15% (N = 1 case), chlamydia by 4% (N = 26 cases), and would pro-
vide no additional reduction to syphilis and HIV incidence.
In relation to the control of STI transmissions in prison, a condom distribution program is
predicted to have varying success. For syphilis and gonorrhoea, condoms are predicted to vir-
tually eliminate new infections and the possibility of self-sustaining outbreaks; however, even
combined with a screening on arrival program, condoms were insufficient to reduce chlamydia
prevalence below self-sustaining levels. To control chlamydia transmission, additional screen-
ing of the existing prison population would be required. The prevalence of HIV and hepatitis B
is so low that the effects of condoms are predicted to be small, however the high and ongoing
costs associated with treatment means that even a few averted cases are likely to have signifi-
cant cost benefits.
Supporting Information
S1 Fig. Entry into the hepatitis B model. For the hepatitis B model, each month Nsi+Nli new
prisoners arrive in prison i and are apportioned to compartments according to sexual activity
in prison, prior incarceration status vaccination status and community or prison infection
prevalence.
(TIF)
S2 Fig. Uncertainty distributions for non-STI specific parameters and hepatitis B vaccina-
tion coverage parameters. Assumed uncertainty of parameters for: the proportion of prisoners
who are sexually active (Sex); the proportion of condoms used for sex (Used); the proportion of
sexual acts that use condoms when available (Condom); the proportion of prisoners with a his-
tory of incarceration (Prior); the proportion of prisoners who are screened on arrival when the
intervention is available and the rate they are screened at (in months); and the prevalence of hep-
atitis B vaccination in the community [VacHB (Community)] and in prison [VacHV (Prison)].
(TIF)
S3 Fig. Uncertainty distributions for STI specific parameters. Assumed uncertainty of
parameters for the community STI prevalence (proportion of community infected), the risk of
transmission per sexual act, the effective detection and treatment rate (in months), the duration
of latency (in months) and the window period (in months).
(TIF)
S4 Fig. Uncertainty analysis infections averted.Histograms of HIV, Hepatitis B (HBV), syph-
ilis (SYP), chlamydia (CHL) and gonorrhoea (GON) infections prevented per annum from
2000 simulations using random parameter draws, condom intervention (left) and condom
with screening on arrival intervention (right).
(TIF)
S5 Fig. Uncertainty analysis prevalence results.Histograms of HIV, Hepatitis B (HBV), syph-
ilis (SYP), chlamydia (CHL) and gonorrhoea (GON) prevalence in prison using 2000 random
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parameter draws, before any interventions (left), after the introduction of condoms (middle),
and after the introduction of condoms and a screening on arrival intervention (right).
(TIF)
S1 File. Model equations, new arrivals in the hepatitis B model and the uncertainty analy-
sis. Detailed description of the equations used for each model; the apportioning of new arrivals
in the hepatitis B model, dealing with immunity through the vaccination; and the distributions
used for individual parameter uncertainties, the resulting distributions of number of infections
prevented per year (with condoms and with condoms + screening on arrival), and the resulting
distributions of the prevalence of each infection (without condoms, with condoms and with
condoms + screening on arrival).
(DOCX)
S1 Table. Parameter uncertainty distributions. The uncertainties of individual parameters
were parameterised as Beta probability distributions with parameters b1 and b2.
(DOCX)
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